Links : [H]ard|Folding [H]ard|OCP
Local

Pacific

Mountain

Central

Eastern

GMT

[H] Member Login

Remember

Stanford's goal: to understand protein folding, protein aggregation, and related diseases.



What are proteins and why do they "fold"? Proteins are biology's workhorses -- its "nanomachines." Before proteins can carry out their biochemical function, they remarkably assemble themselves, or "fold." The process of protein folding, while critical and fundamental to virtually all of biology, remains a mystery. Moreover, perhaps not surprisingly, when proteins do not fold correctly (i.e. "misfold"), there can be serious effects, including many well known diseases, such as Alzheimer's, Mad Cow (BSE), CJD, ALS, and Parkinson's disease.

What does Folding@Home do? Folding@Home is a distributed computing project which studies protein folding, misfolding, aggregation, and related diseases. Stanford uses novel computational methods and large scale distributed computing, to simulate timescales thousands to millions of times longer than previously achieved. This has allowed us to simulate folding for the first time, and to now direct Stanford's approach to examine folding related disease.



How to Join | Project Faqs | Project Add-ons | Statistics | Download Client
New Members
[ 5 ]
 M_Bohde09/01/14 
 electro2u09/01/14 
 ozo08/29/14 
 Corey08/28/14 
 SV08/26/14 
MD Anderson cost analysis shows proton therapy less costly than IMRT for advanced head/neck cancers
Method to expand blood stem cells could lead to new cancer treatment
Key mechanism in cancer metastasis identified offering potential for therapy
New imaging technique shows how cocaine shuts down blood flow in mouse brains
How repressing the repressors may drive tissue-specific cancers
Metastasis more likely to occur with clusters of circulating tumor cells rather than single cells
New type of cell movement discovered
Research reveals mechanism behind cell protein remodeling within a family of cancers
How high-fat diets promote intestinal cancer
How premalignant cells can sense oncogenesis and halt growth
Exploiting a common cancer defense shows promise as a new cancer therapy
Targeted therapy for hepatocellular carcinoma using nanotechnology and the thunder god vine
New ESC registries launched on cardiac oncology and ACS
Leading scientists call for a stop to non-essential use of fluorochemicals
Versatile multi-tasking nanoparticles offer a wide variety of diagnostic and therapeutic applications
Acoustic device that separates tumor cells from blood cells could help assess cancer's spread
Sound waves separate tumor and blood cells
Probing cancer's molecular make-up
New approach to treating cancer: personalized radiation therapy during - instead of after - cancer surgery
Knowledge is power: UCLA study finds men who are uneducated about their prostate cancer have difficulty making good treatment choices
Gentle separation of cells using tilted acoustic tweezers
The epigenetic signature could be key to glioblastoma's therapeutic resistance
Potential for early attack on malaria offered by cancer-fighting drugs
Depression untreated in many cancer patients, new approach could help
Discovery of navigation system used by cancer, nerve cells
Older adults who volunteer are more likely to be happier and healthier
Pilot study of socially-assistive robots that help children with autism to learn imitative behavior
Late and early onset Alzheimer's affect brain function in similar way
Memory boosted by electric current to brain: finding has implications for stroke, Alzheimer's and brain injury
Marijuana compound shows promise for treating Alzheimer's disease in preclinical study
Unprecedented detail of intact neuronal receptor should serve as template and guide for the design of therapeutic compounds
Mindfulness training can improve quality of life for memory impaired and their caregivers
Weight loss following bariatric surgery leads to improved brain function, could reduce risk of Alzheimer's in obese people
APOE, diagnostic accuracy of CSF biomarkers for Alzheimer disease
Missing protein associated with early signs of dementia
Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's
Cognitive impairment increases risk of stroke
Retinal thinning can be used as an early marker for frontotemporal dementia, prior to the onset of cognitive symptoms
Cognitive impairment 'associated with a higher risk of stroke'
New mouse line offers new insights for treatments of epilepsy, Alzheimer's
Alzheimer's disease: rAAV/ABAD-DP-6His attenuates oxidative stress induced injury of PC12 cells
Dementia risk increased for obese people in 30s, but reduced for obese seniors
Pulse pressure and elasticity of arteries in the brain mapped for arterial health and aging
Alzheimer's disease: are we close to finding a cure?
Zebrafish help to unravel Alzheimer's disease
Atypical antipsychotic drug use increases risk for acute kidney injury
Examining the brain's chromosomal make-up in relation to Alzheimer's disease
DNA methylation in brain 'linked to Alzheimer's disease'
Researchers find RNA-targeted drug candidate for Lou Gehrig's disease
Understanding of Alzheimer's disease improved by epigenetic breakthrough
Are molecular mechanisms to blame for how stress affects us?
New type of cell movement discovered
Research reveals mechanism behind cell protein remodeling within a family of cancers
Artificial virus improves delivery of new generations of pharmaceuticals
Stem cell breakthrough for 'Cinderella cells'
Neanderthals and modern humans co-existed for thousands of years
Scientists grow fully functional thymus in mice from scratch
MRC publishes a review of the UK molecular pathology landscape
One of the biggest challenges for single-cell research is picking out only one cell from a collection of millions - problem solved
Treating pain by blocking the 'chili-pepper receptor'
Slippery material for lubricating joints inspired by nature
Scripps research institute chemists uncover powerful new click chemistry reactivity
Parasitic worms sniff out their victims as "cruisers" or "ambushers"
Scientists build first functional 3D brain tissue model
"Dimmer switch" drug idea could tackle schizophrenia
Cell signaling pathway linked to obesity and Type 2 diabetes
Probes that repair genes inspired by butterfly proboscis
The speed of a signal seals the fate of an embryonic cell
Scientists reproduce evolutionary changes by manipulating embryonic development of mice
New insights into why adolescents carry meningitis-causing bacteria
Self-assembling anti-cancer molecules created in minutes, like a self-assembling 'Lego Death Star'
Softening of human features 'coincided with technological breakthrough'
Chemists create nanofibers using unprecedented new method
Wound closure involves cooperative compression
Biomedical discoveries accelerated by see-through organs and bodies
  • Stickies: 0
  • News Articles: 158
  • Pages: 32
Protein folding and viral infection
King_N
[H]ard|Folding Administrator


Posts: 103
Points: 2,847,992
Work Units: 6,671

Posted: Mon Feb 27, 2012 02:00 am
Stanford has released a few new articles.

Protein folding and viral infection

Quote:
Understanding protein folding has many possible areas of biological and biomedical impact. For example, consider one of the major research areas of the Kasson lab at the University of Virginia, namely how the influenza virus infects cells. In the past, Dr. Kasson and Dr. Pande have studied two aspects of this: how the influenza virus recognizes cell-surface receptors so it infects the "right" cell types and how small vesicles fuse.


Dr. Kasson's group is now looking at the function of the viral protein that controls cell entry, a protein called hemagglutinin. The hemagglutinin protein interacts with cell membranes: one piece inserts into the membrane, refolds, and alters the membrane in some unknown manner to promote viral entry. Another piece links the viral and cell membranes and refolds to bring the two together. We are running simulations on Folding@Home to examine each of these pieces. Dr. Kasson's laboratory also looks at these processes experimentally.


Full Article here.


Protein Folding and Molecular Recognition

Quote:
In the past a couple of years, the FAH has greatly helped us on our research on understanding the mechanisms of the molecular recognition processes. Molecular recognition, such as enzymes need to recognize their substrates and drugs have to be designed to specifically bind to certain receptors, is crucial to biology and medicine. Experimentally probing the chemical details of molecular recognition events is challenging, while computer simulations have the potential to provide a detailed picture of such events. With the help of the FAH donors, we are performing large-scale simulations on a group of Periplasmic Binding Proteins aiming to reveal the general relationships between protein structures, its intrinsic dynamics, and mechanism of recognition process.


Full Article here.


LTMD: Key new technology for accelerating folding and misfolding simulations in FAH


Quote:
The Izaguirre Lab at the University of Notre Dame (http://www.nd.edu/~lcls) has been collaborating with the Pande Lab at Notre Dame to produce a new GPU core that leverages the amazing speed of OpenMM implicit-solvent force calculations (the heart of the GPU core in Folding@home) with new Long Timestep Molecular Dynamics (LTMD). This combination currently allows nearly a 10-fold speedup over OpenMM for systems as small as the WW domain (35 residues, 544 atoms) up to the Lambda repressor (80 residues, 2000 atoms). This translates into about 10 microseconds per day of simulation, which brings single trajectory millisecond simulations closer to FAH.

In collaboration with Cauldron Development (lead by Joseph Coffland, primary developer of the Folding@home client and also some cores), we hope to produce a GPU core that might be the first hybrid CPU-GPU core. There are technical questions on how to best do this, and we will engage our enthusiastic beta-tester GPU donors to discuss how to best approach this core when we are closer to production mode.


Full Article here.

Protein In The Brain Could Be A Key Target In Controlling Alzheimer's
King_N
[H]ard|Folding Administrator


Posts: 103
Points: 2,847,992
Work Units: 6,671

Posted: Sun Jan 29, 2012 06:43 pm
This has been a relatively quiet month, there has been no new news released by the Stanford folding team, so there is not much I can report.

However I did run across this interesting Alzheimer's news article.

Quote:
A protein recently discovered in the brain could play a key role in regulating the creation of amyloid beta, the major component of plaques implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine.

A group led by Domenico Pratico, professor of pharmacology and microbiology and immunology at Temple, discovered the presence of the protein, called 12/15-Lipoxygenase, in the brain three years ago.

"We found this protein to be very active in the brains of people who have Alzheimer's disease," said Pratico. "But three years ago, we didn't know the role it played in the development of the disease."

Following two years of study, the Temple researchers have found that the protein is at the top of a pathway and controls a biochemical chain reaction that begins the development of Alzheimer's.


Full Article here
Multiple Myeloma First Risk Genes Discovered
King_N
[H]ard|Folding Administrator


Posts: 103
Points: 2,847,992
Work Units: 6,671

Posted: Thu Dec 29, 2011 07:55 pm
It's been a rather slow month for news.

Stanford has finished their stats re-credit, they ask that you let them know if there is still problems.


On the cancer news front

Quote:
According to a paper published online in Nature Genetics, a team of scientists led by The Institute of Cancer Research (ICR) has demonstrated for the first time that a person's genes influence their risk of developing multiple myeloma, a cancer of plasma cells, which is a type of white blood cell responsible for the production of antibodies.


Full Article here


Also there was a slight problem with the database earlier this month, the site was down for a short time while the issue was dealt with. Everything appears to be back to normal.

Recent video about Folding@home from the Stanford News Service
King_N
[H]ard|Folding Administrator


Posts: 103
Points: 2,847,992
Work Units: 6,671

Posted: Sat Nov 26, 2011 05:25 pm
Stanford has released a video about Folding.



View Video here


Also Stanford has made changes to the "Big Advanced Projects" which will go into effect Jan 16th.


Quote:

Big Advanced (BA) is an experimental type of Folding@home WUs intended for the most powerful machines in FAH. However, as time goes on, technology advances, and the characteristics associated with the most powerful machines changes. Due to these advances in hardware capabilities, we will need to periodically change the BA minimum requirements. Thus, we are shortening the deadlines of the BA projects. As a result, assignments will have a 16 core minimum. To give donors some advance warning, we are announcing this now, but the change will take place in 2 months: no earlier than on Monday January 16, 2012.

We understand that any changes to how FAH works is a disruption for donors, and we have been trying to minimize such changes. For that reason, we are not changing the points system at this time.

However, we want to emphasize that the BA program is experimental and that donors should expect changes in the future, potentially without a lot of notice (although we will try our best to give as much notice as we can). In particular, as hardware evolves, it is expected that we will need to change the nature of the BA WUs again in the future.
Folding Client 7.1.38 Released
King_N
[H]ard|Folding Administrator


Posts: 103
Points: 2,847,992
Work Units: 6,671

Posted: Tue Oct 25, 2011 03:05 pm
A New Folding Client has been released, v7.1.38

Changelog for the last few updates is below.

Quote:
v7.1.38:
Fixed network connection dropping.


v7.1.37:
Added missing wraplabel.py file to FAHControl.
Changed socket error message verbosity.
Fail WU on UNSTABLE_MACHINE immediately & return for partial credit. #615


v7.1.36:
Fixed a potential socket connection bug. Maybe related to #734.
Added several NVidia cards to GPUs.txt. #737.
Improved Linux on battery detection. #738.
Print WU error state on WU status line.
Emit correct exception on FAH transaction failure. #615.
Fixed debian package install core permissions problem. #732.
Removed core byte order warning. #602.
Added GPL link to FAHControl about. #736.
Ask user, team, passkey and mode during .deb package install. #739.


v7.1.35:
Added 'Enchanter' theme. #731
Renamed 'Wimp' to 'Windows-Default'. #731
Unminimize FAHControl window on unhide. #567
Better core download failure message. #161
Cleaned up project descriptions using html2text.py.
Store project data in client DB.
Use system default font size. #733
Added project info to viewer. #575.
Added clickable buttons to viewer.
Fixed FAHViewer crash introduced in v7.1.34.
Fixed mouse wheel scrolling in FAHControl. #463.
Fixed color difference for text boxes. #698.
Changed FAHControl window name. #711.


v7.1.34:
Fixed CPU consumption in client connections. #702
Really fixed "Wrong architecture" bug on 32-bit Ubuntu. #599
Only warn on config errors. #722
Log error and continue of command server fails to initialize.
Fixed Slot configuration text. #717
Use -1 or 0 for CPUs default to be consistent with GPU options. #717
Disabled no longer supported AMD X1300 - 1900 GPUs.
Added "OpenGL Render" to info in FAHViewer. (For blacklisting)
Added 'override-blacklist' option to FAHViewer. (Nothing black listed yet)
'OK' -> 'Save' in FAHViewer preferences window. #724
Fixed NVIDIA_DEV.1244.01 = "NVIDIA GeForce GTX 550 Ti" detection.
Added the 'Wimp' theme and win32 theme engines. #723
Made 'Wimp' theme the default in Windows. #713
Added heartbeat to viewer<->client connection to timeouts dead connections.
Stop trying FAILED, FAULTY and DUMP reports if WS connection was made. #728
Check WS server versions for unreasonable values. #728.


Client Download: here



Stanford also released a paper showing the Comparison between FAH and Anton's approaches.

Quote:
Right now, the two most powerful supercomputers for studying protein folding are Folding@home and a very impressive special purpose computer from DE Shaw Researched, called ANTON. We're often been asked "how do they compare?" The approaches are very different, so comparisons aren't completely straightforward. ANTON takes the traditional approach to studying protein folding, where one performs a few (often 1 or 2) long trajectories to study the process. Folding@home takes a statistical approach, which has two primary benefits: 1) it can access folding on dramatically longer timescales (milliseconds, instead of microsecond folding events over a single long trajectory) and 2) it can give statistically significant results on those long timescales.

The main concern about the method in FAH is that since it is such a radically new approach, does it work reliably? Previous tests of FAH have been to experiment, which is the gold standard test, but also brings in other issues, such as how good are our models of reality. Thus, while FAH's approach has done well compared to experiment, it is useful to compare FAH and ANTON directly, since they use the same models, etc. Comparison of our statistical approach (using Markov State Models, aka MSMs) directly with data from ANTON would go a long way to showing that the MSM approach works for even non-trivial systems (they have been previously tested for long dynamics on small systems).


Full Article: here


  • Stickies: 0
  • News Articles: 158
  • Pages: 32
Administrator Council News Member

[H]ard|Folding Copyright © 2001 - 2014 by King_N,   [H]ard|OCP Copyright © 1998 - 2013 by Kyle Bennett

All trademarks used are properties of their respective owners. All rights reserved.